Parkinsonian Syndrome
📧 Sign up to get email alerts when something new happens for Parkinsonian Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients [Phase 3]
Phase 3 trial update assessing DaTSCAN Ioflupane SPECT imaging for diagnosing Parkinsonian syndromes in Chinese patients has completed with …
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome [Phase 2]
Phase 2 clinical trial evaluating brain imaging with nuclear technology in individuals with Parkinson's disease and Parkinsonian syndrome co…
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes [Phase 3]
Phase 3 trial evaluating [123I]NAV5001 as an imaging agent for diagnosing Parkinsonian syndromes has been terminated.
-
CLINICAL_TRIALS withdrawal · 2017-09-13Clinical Trial Update: A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes [Phase 3]
Phase 3 trial evaluating [123I]NAV5001 for imaging Parkinsonian syndromes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty [Phase 2]
Phase 2 study evaluating individuals with Parkinsonian symptoms where diagnostic uncertainty exists; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease [Phase 2]
A Phase 2 study evaluating imaging, clinical and biochemical biomarkers for Parkinson's disease and Parkinsonian syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families [Phase 2]
Phase 2 clinical trial update examining imaging and genetic biomarkers for onset and progression of Parkinson disease in high-risk families.…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
This clinical trial update notes the completion of a study on neurophysiologic changes in individuals with Parkinson's disease. The study wa…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease [Phase 2]
This update notes the completion of a Phase 2 study evaluating the effects of dopaminergic medications on dopamine transporter imaging in Pa…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease [NA]
A completed clinical trial studying the effects of dopaminergic medications on dopamine transporter density in people with Parkinson disease…